Ritulasta Injection
Marketer
PlasmaGen Biosciences Pvt Ltd
Salt Composition
Rituximab (100mg)
Overview Ritulasta Injection
Rituximab injection is indicated for various conditions including non-Hodgkin's lymphoma, rheumatoid arthritis, chronic lymphocytic leukemia, and vasculitis (granulomatosis with polyangiitis and microscopic polyangiitis). Administered intravenously under medical supervision, the dosage and frequency are determined by the physician based on the specific condition and may vary. Precise adherence to the prescribed regimen is crucial; incorrect usage or overdose can lead to severe adverse reactions. Therapeutic effects might not be apparent immediately; consistent use is essential unless discontinued by your doctor. Commonly reported side effects involve headache, fatigue, swelling, infections, and alopecia. Rituximab can decrease blood cell counts, increasing infection risk, necessitating regular blood tests, including hepatitis B monitoring. Prior to treatment, inform your physician of any pre-existing cardiac or hepatic conditions, planned surgeries or immunizations, and all other medications, including anti-infectives, as drug interactions are possible. This medication is contraindicated during pregnancy and lactation; reliable contraception for both partners is strongly advised throughout the treatment period.
Uses of Ritulasta Injection
Chronic lymphocytic leukemia, rheumatoid arthritis, granulomatosis with polyangiitis, microscopic polyangiitis, and non-Hodgkin lymphoma.
Major Benefits of Ritulasta Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Ritulasta Injection:
- Headache
- Weakness
- Infection
- Chills
- Decreased white blood cell count (neutrophils)
- Fever
- Infusion site reaction
- Lymphopenia
- Abdominal pain
- Back pain
How to use Ritulasta Injection:
This medication will be administered by your physician or registered nurse; please do not attempt self-medication.
How Ritulasta Injection works:
Ritulasta Injection, a monoclonal antibody therapy, neutralizes the aberrant activity of B lymphocytes, providing therapeutic benefit in rheumatoid arthritis and selected malignancies.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using Ritulasta Injection concurrently with alcohol. Physician consultation is recommended.
PregnancyCONSULT YOUR DOCTOR
Administering Ritulasta Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible hazards prior to prescription. Physician consultation is advised.
Breast feedingSAFE IF PRESCRIBED
Administration of Ritulasta Injection while breastfeeding appears to pose minimal risk. Available human data indicates negligible danger to the infant.
DrivingCONSULT YOUR DOCTOR
Ritulasta Injection's impact on driving ability is undetermined. Refrain from driving if you develop symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
Ritulasta Injection appears to pose minimal risk for individuals with kidney impairment. Current evidence indicates dose modification may be unnecessary, though this is based on limited information. Physician consultation is recommended.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding Ritulasta Injection's use in individuals with hepatic impairment. Physician consultation is advised. Ritulasta Injection is contraindicated in patients experiencing active liver disease or a history of viral hepatitis due to the risk of infection recurrence.
What if you forget to take Ritulasta Injection :
Should you forget a scheduled Ritulasta Injection, seek your physician's advice.
Facts to Know About Ritulasta Injection
| Label | Value |
|---|---|
| Chemical Type | Monoclonal antibody |
| Developing Habits | No. |
| Treatment Category | Cancer Therapeutics |
| Behavior Class | Anti-CD20 Therapy |
3,018 People bought this recently